Research Reveals New Broad-Spectrum Antibiotic Containing Arsenic

Photo of author

(Newswire.net — December 8, 2022) Orlando, FL — In the United States, antibiotic resistance claims the lives of over 35,000 individuals. The scientific community continues to carry out studies in looking into the various aspects of this global public health issue. 

A study was carried out by researchers from Florida International University’s Herbert Wertheim College of Medicine.

In this research, the investigators discovered a new broad-spectrum antibiotic that has arsenic. 

The findings of this research were published in Natures Communication Biology.

It was carried out in collaboration with Barry P. Rosen, Masafumi Yoshinaga, Venkadesh Sarkarai Nadar, and others from the Department of Cellular Biology and Pharmacology, and Satoru Ishikawa and Masato Kuramata from the Institute for Agro-Environmental Sciences, NARO in Japan. 

“The antibiotic, arsinothricin or AST, is a natural product made by soil bacteria and is effective against many types of bacteria, which is what broad-spectrum means,” said Rosen, co-senior author of the study published in the Nature journal, Communications Biology. 

“Arsinothricin is the first and only known natural arsenic-containing antibiotic, and we have great hopes for it.”

While it contains arsenic, scientists reveal they actually tested AST toxicity on human blood cells. Further, they reported that it doesn’t kill human cells in tissue culture.

“People get scared when they hear the word arsenic because it can be a toxin and carcinogen, but the use of arsenicals as antimicrobials and anticancer agents is well established,” says Rosen.

The World Health Organization (WHO) has warned that “a growing number of infections — such as pneumonia, tuberculosis, gonorrhea, and salmonellosis — are becoming harder to treat as the antibiotics used to treat them become less effective.” 

“We are running out of tools to fight these diseases. We need a new potent antibiotic to solve this problem,” says Yoshinaga, the other co-senior author. 

“We showed that this new novel arsenic compound can be a potent antibiotic.”

Today, scientists are increasingly warning against a global health threat called antibiotic resistance. There are many studies looking into the techniques helpful for lessening antibiotic-resistant rates. One is through the use of D-mannose, which is a therapeutic sugar found in cranberry. 

Through its UTI-fighting potential, it could work in reducing or eliminating the need for antibiotics. This means it could help lessen the risk of antibiotic overuse, which leads to antimicrobial resistance. The therapeutic goodness of this remedy may be obtained through the use of unique and superior-quality formulas like Divine Bounty D-mannose.

Every Vegetarian and odorless capsule of this formula does not contain nasty and unwanted ingredients, which experts warn against exposure. It is free from additives, binders, and fillers like hydrogenated oil from genetically modified (or non-organic) soya beans. 

This ingredient has long been linked with side effects like diabetes, cardiovascular problems, nervous system problems, and the non-absorption of essential fatty acids. (http://www.amazon.com/D-Mannose-600mg-Cranberry-Dandelion-Extract/dp/B01LX5KGF0)

About Divine Bounty

Divine Bounty is a family-owned brand that manufactures high-quality turmeric curcumin supplements. Passionate about the potential health benefits of turmeric, the team behind Divine Bounty has carefully researched and sourced only the best ingredients to create the ideal blend of turmeric curcumin. More details are available at http://www.DivineBounty.com.

Divine Bounty

12001 Research Parkway
Suite 236 A
Orlando, FL 32826
United States
4075457738
media@divinebounty.com
http://www.divinebounty.com/